However, other studies demonstrate that p21 induction in daunomycin treated breast and colon carcinoma cell lines does not involve NF-κB though the p21 promoter harbors p53 responsive elements and a functional NF-κB binding site in these cells [50]. The gene discussed is CDKN1A; the disease is colon carcinoma.